Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome

Generation Sequencing ◽

Minimal Residual ◽

Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations

Genes Chromosomes and Cancer ◽

10.1002/gcc.21955 ◽

2012 ◽

Vol 51 (7) ◽

pp. 689-695 ◽

Cited By ~ 71

Author(s):

Felicitas Thol ◽

Britta Kölking ◽

Frederik Damm ◽

Katarina Reinhardt ◽

Jan-Henning Klusmann ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Next Generation Sequencing ◽

Myeloid Leukemia ◽

Residual Disease ◽

Disease Monitoring ◽

Generation Sequencing ◽

Minimal Residual ◽

Comparison of flow cytometry and next‐generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute’s practical clinical experience

International Journal of Laboratory Hematology ◽

10.1111/ijlh.13711 ◽

2021 ◽

Author(s):

Paul McGowan ◽

Stephen Hyter ◽

Wei Cui ◽

Regina M. Plummer ◽

Andrew K. Godwin ◽

...

Keyword(s):

Flow Cytometry ◽

Acute Myeloid Leukemia ◽

Next Generation Sequencing ◽

Myeloid Leukemia ◽

Residual Disease ◽

Disease Monitoring ◽

Generation Sequencing ◽

Minimal Residual ◽

Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia

Oncotarget ◽

10.18632/oncotarget.4333 ◽

2015 ◽

Vol 6 (26) ◽

pp. 22812-22821 ◽

Cited By ~ 26

Author(s):

Jean-Emmanuel Bibault ◽

Martin Figeac ◽

Nathalie Hélevaut ◽

Céline Rodriguez ◽

Sabine Quief ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Next Generation Sequencing ◽

Myeloid Leukemia ◽

Residual Disease ◽

Disease Monitoring ◽

Generation Sequencing ◽

Minimal Residual ◽

Tandem Duplications ◽

Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03530-9 ◽

2021 ◽

Author(s):

Hong Wang ◽

Xue-Qian Li ◽

Tian-Tian Chu ◽

Shi-Yu Han ◽

Jia-Qian Qi ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Residual Disease ◽

Hematopoietic Stem ◽

Cebpa Mutations ◽

Minimal Residual ◽

A Phase 1 Multi-Dose Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) in Adults with Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission with Minimal Residual Disease (MRD) (NCT04310592)

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00199-8 ◽

2021 ◽

Vol 27 (3) ◽

pp. S161-S162

Author(s):

James McCloskey ◽

William B. Donnellan ◽

Solveig Ericson ◽

Erica C Rave ◽

Robert J Hariri

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Phase 1 ◽

Hematopoietic Stem ◽

Secondary Acute Myeloid Leukemia ◽

Dose Study ◽

Minimal Residual ◽

Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia

Translational Oncology ◽

10.1016/j.tranon.2021.101119 ◽

2021 ◽

Vol 14 (8) ◽

pp. 101119

Author(s):

Xiaoyan Chen ◽

Suyu Zong ◽

Meihui Yi ◽

Chao Liu ◽

Bingrui Wang ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Disease Monitoring ◽

Childhood Acute Myeloid Leukemia ◽

Minimal Residual ◽

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia

Leukemia Research ◽

10.1016/j.leukres.2011.11.002 ◽

2012 ◽

Vol 36 (3) ◽

pp. 316-323 ◽

Cited By ~ 36

Author(s):

Emna Abdelhamid ◽

Claude Preudhomme ◽

Nathalie Helevaut ◽

Olivier Nibourel ◽

Claude Gardin ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Tandem Duplication ◽

Residual Disease ◽

Disease Monitoring ◽

Internal Tandem Duplication ◽

Flt3 Internal Tandem Duplication ◽

Minimal Residual ◽

Corrigendum to ‘IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?’ Clinical Biochemistry 61 (2018) 34–39

Clinical Biochemistry ◽

10.1016/j.clinbiochem.2018.10.005 ◽

2019 ◽

Vol 63 ◽

pp. 161

Author(s):

Lucie Petrova ◽

Filip Vrbacky ◽

Miriam Lanska ◽

Alzbeta Zavrelova ◽

Pavel Zak ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Clinical Biochemistry ◽

Residual Disease ◽

Disease Monitoring ◽

Idh1 And Idh2 Mutations ◽

Minimal Residual ◽

Quantitative detection ofIDH2mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations inNPM1gene

Leukemia & Lymphoma ◽

10.3109/10428194.2012.727414 ◽

2012 ◽

Vol 54 (4) ◽

pp. 867-870 ◽

Cited By ~ 7

Author(s):

Ivana Jeziskova ◽

Filip Razga ◽

Martina Toskova ◽

Dana Dvorakova ◽

Shira Timilsina ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Quantitative Detection ◽

Disease Monitoring ◽

Minimal Residual ◽

Minimal residual disease monitoring in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation using interphase fluorescence in situ hybridization and real-time quantitative reverse transcription PCR

Chinese Journal of Cancer ◽

10.5732/cjc.009.10250 ◽

2010 ◽

Vol 29 (2) ◽

pp. 194-199 ◽

Cited By ~ 3

Author(s):

Hong-Qian Zhu ◽

Xiao-Li Liu ◽

Lan-lin Song ◽

Qi-Fa Liu ◽

Fan-Yi Meng ◽

...

Keyword(s):

Stem Cell ◽

In Situ Hybridization ◽

Myeloid Leukemia ◽

Residual Disease ◽

Disease Monitoring ◽

Hematopoietic Stem ◽

Reverse Transcription Pcr ◽

Minimal Residual